Mediterranean diet is associated with liver histology in patients with non alcoholic fatty liver disease;La dieta mediterránea se asocia con la histología hepática en pacientes con enfermedad del hígado graso no alcohólico

Nutricion Hospitalaria

Volumn 32, Issue 6, 2015, Pages 2518-2524

  Aller, Rocio ^a   Izaola, Olatz ^a,b   de la Fuente, Beatriz ^a   de Luis, Daniel ^a,b  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Insulin resistance; Liver biopsy; Mediterranean diet; Nonalcoholic fatty liver disease

Indexed keywords

ADULT; BODY MASS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LIVER; MALE; MEDITERRANEAN DIET; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PATHOLOGY; PATIENT COMPLIANCE;

ADULT; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIET, MEDITERRANEAN; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PATIENT COMPLIANCE;

EID: 84949999325     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2015.32.6.10074     Document Type: Article

References (35)

1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proc 1980;55:434-438.
2. Vuppalanchi R, Chalasani N. NAFLD and non alcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology 2009;49:306-317.
3. Clark JM. The epidemiology of NALFD in adults. J Clin Gastroenterol 2006;40:s5-s10
4. Hamaguchi M, Kojima T, Ohborn A, Takeda N, Pukui M, Kato T. Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J Gastroenterol 2012;18:156-167.
5. De Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Conde R, Bellido D. Influence of insulin resistance and adipocytokines on elevated serum alanine aminotransferase in obese patients. Arch Med Res 2008; 39: 110-114
6. Tan HH, Chang JP. Non-alcoholic fatty liver disease. Proceedings of Singapore Healthcare 2010; 19: 36-50.
7. Socha P, Horvath A, Vajro P. Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review. J Pediatr Gastroenterol Nutr 2009; 48: 587-96.
8. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 2010;92:1189e96.
9. Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB. The effect of mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 2011;57:1299e313.
10. Kontogianni MD, Tileli N, Margariti A, Georgoulis M, Deutsch M, Tiniakos D, et al Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr 2014 Aug;33(4):678-83.
11. Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S, et al AM The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol 2013 ;59:138-43.
12. Trovato FM, Catalano D, Martines GF, Pace P, Trovato GM. Mediterranean diet and non-alcoholic fatty liver disease.: The need of extended and comprehensive interventions. Clin Nutr 2014 Jan 31. pii: S0261-5614(14)00043-0. doi: 10.1016/j.clnu.2014.01.018.
13. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: The smaller the sample, the milder the disease. J Hepatol 2003;39:239-44
14. Martínez-González MA, Fernández-Jarne E, Serrano-Martínez M, Marti A, Martinez JA. Mediterranean diet and reduction in the risk of a first acute myocardial infarction: an operational healthy dietary score. Eur J Nutr 2002;41: 153–160
15. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-414.
16. Meier U, Gressner M. Endocrine regulation of energy metabolis: review of pathobiochemical and clinical chemical aspects of leptin, Ghrelin, adiponectin, and resistin. Clinical Chemstry 2004;50:1511-1525.
17. Suominen P. evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations. Clin Chem 2004;50:219-221.
18. De Lorgeril M, Salen P, Martin JL, Mamelle N, Monjaud I, Touboul P, et al Effect of a mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease. Insights into the cardioprotective effect of certain nutriments. J Am Coll Cardiol 1996;28:1103–1108
19. Esposito K, Maiorino MI, Ceriello A, Giugliano D. Prevention and control of type 2 diabetes by Mediterranean diet: a systematic review. Diabetes Res Clin Pract 2010;89:97–102
20. Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S, et al The mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol 2013;59:138e43
21. Diabetes Prevention Program Research Group, Reduction in the incidence of type 2 diabetes with lifestyle intervention or Metformin. N Engl J Med 2002. 6(346): p. 393-403.
22. Aller R, de Luis D, Pacheco D, Velasco MC, Izaola O, Sagrado MG. Insulin resistance predicts steatosis and fibrosis in morbidly obese patients undergoing bariatric surgery. J Investig Med 2012;60:1005-8.
23. Marchesini G, Brizi M, Morselli-Labate A, Bianchi G, Bugianesi E, McCullough AJ. Association of nonalcoholic fatty liver disease with insulin resistance. Am J of Medicine 1999:107:450-454.
24. Sanyal AJ, Campbell Sargent C, Mirshashi F, Rizzo WB, Contos MJ, Sterling RK et al Nonalcoholic steatohepatitis: association of insulin resistance and mitocohondrial abnormalities. Gastroenterology 2001;120:1183-1192.
25. Tsochatzis E, Papatheodoridis GV, Hadziyannis E. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. Scand J Gastroenterol 2008;43:1128–36.
26. Angulo P. NAFLD, obesity, and bariatric surgery. Gastroenterology 2006;130:1848–52.
27. Chitturi S, Farrell G, Frost L. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology 2002;36:403–9.
28. Fernandez Real JM, Vendrell J, Ricart W. Circulating adiponectin and plasma fatty acid profile. Clinical Chem 2005;51:603-609.
29. de Luis DA, Aller R, Izaola O, Sagrado MG, Conde R, Gonzalez JM. Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance. Diabetes Res Clin Pract 2008;79:74-8.
30. de Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Conde R. Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fattyliver disease and obese patients. Nutr Hosp 2010 ;25:730-5.
31. Aller R, de Luis DA, Izaola O, de la Fuente B, Bachiller R. Effect of a high monounsaturated vs high polyunsaturated fat hypocaloric diets in nonalcoholic fatty liver disease. Eur Rev Med Pharmacol Sci 2014;18(7):1041-7.
32. Aller R, Izaola O, Ruiz-Rebollo L, Pacheco D, de Luis DA. Predictive factors of non-alcoholic steatohepatitis: relationship with metabolic syndrome. Nutr Hosp 2015 Jun 1;31(6):2496-502.
33. Jiménez-Cruz A, Gómez-Miranda LM, Díaz Ramírez G, Carvalí Meza N. Y, Bacardí-Gascón M. [Adiposity as a risk factor of non alcoholic fat disease; systematic review]. Nutr Hosp 2014 Apr 1;29(4):771-5.
34. Riveros MJ, Parada A, Pettinelli P. [Fructose consumption and its health implications; fructose malabsorption and nonalcoholic fatty liver disease]. Nutr Hosp 2014 Mar 1;29(3):491-9.
35. Bezerra Duarte S. M, Faintuch J, Stefano JT, Sobral de Oliveira MB, de Campos Mazo DF, Rabelo F, Vanni D, Nogueira MA, Carrilho FJ, Marques Souza de Oliveira CP Hypocaloric high- protein diet improves clinical and biochemical markers in patients with nonalcoholicfatty liver disease (NAFLD). Nutr Hosp 2014 Jan 1;29(1):94-101.